EP1124417A2 - Zusammensetzungen, die das wachstum von pflanzenzellen regulierende verbindungen enthalten, und verfahren zu ihrer verwendung - Google Patents

Zusammensetzungen, die das wachstum von pflanzenzellen regulierende verbindungen enthalten, und verfahren zu ihrer verwendung

Info

Publication number
EP1124417A2
EP1124417A2 EP99956730A EP99956730A EP1124417A2 EP 1124417 A2 EP1124417 A2 EP 1124417A2 EP 99956730 A EP99956730 A EP 99956730A EP 99956730 A EP99956730 A EP 99956730A EP 1124417 A2 EP1124417 A2 EP 1124417A2
Authority
EP
European Patent Office
Prior art keywords
plant
tissue
plant cell
cell
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99956730A
Other languages
English (en)
French (fr)
Inventor
Jhy-Jhu Lin
Nacyra Assad-Garcia
Jianqing Lan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Life Technologies Corp
Original Assignee
Invitrogen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Invitrogen Corp filed Critical Invitrogen Corp
Publication of EP1124417A2 publication Critical patent/EP1124417A2/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
    • A01H4/00—Plant reproduction by tissue culture techniques ; Tissue culture techniques therefor
    • A01H4/002—Culture media for tissue culture
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/10—Aromatic or araliphatic carboxylic acids, or thio analogues thereof; Derivatives thereof

Definitions

  • compositions Comprising Plant Cell Growth Regulating Compounds and Methods of Use Thereof
  • the present invention is in the fields of plant and plant cell biology.
  • the invention relates generally to compositions comprising one or more compounds that regulate the growth of plants and plant cells. More particularly, the invention relates to compositions, such as culture media, comprising one or more auxin-like compounds, including mono-, di- or multi-substituted phenylacetic acid compounds or ester or salt derivatives thereof, including compounds such as 2-, 3-, and 4-bromophenylacetic acid and derivatives thereof and the like.
  • the invention also relates to such compositions further comprising one or more additional compounds that regulate the growth of plants and plant cells, including cytokinins (such as zeatine, kinetin, and 6-benzylaminopurine (BAP)) and giberellins.
  • cytokinins such as zeatine, kinetin, and 6-benzylaminopurine (BAP)
  • giberellins giberellins.
  • the invention also relates to methods of regulating the growth of plants and plant cells comprising contacting a plant cell with one or more of the above- described compositions.
  • the invention also relates to methods for the production and cultivation of genetically modified plants and plant cells comprising obtaining a genetically modified plant or plant cell and contacting the plant or plant cell with one or more of the above-described compositions.
  • the invention also relates to genetically modified plants and plant cells produced by such methods.
  • Plant growth is affected by a variety of physical and chemical factors. Physical factors include available light, day length, moisture and temperature. Chemical factors include minerals, nitrates, co-factors, nutrient substances and plant growth regulators or hormones, for example, auxins, cytokinins and gibberellins.
  • Indole-3-acetic acid is a naturally-occurring plant growth hormone identified in plants. IAA has been shown to be directly responsible for the increase in growth in plants in vivo and in vitro. The characteristics influenced by IAA include cell elongation, internodal distance (height) and leaf surface area. IAA and other compounds exhibiting hormonal regulatory activity similar to that of IAA are included in a class of plant regulators called "auxins.” Preparations based on cytokinins, such as 6-furfurylaminopurine (kinetin) and 6- benzylaminopurine (BAP), are also known to be growth stimulators. However, cytokinin-based preparations are most effective in combination with auxins.
  • cytokinins affect the growth cycle of plants. It is apparent that they affect leaf growth and prevent aging in certain plants. It is a general objective in the field to successfully engineer and regenerate plants of major crop varieties using methods such as tissue culture and genetic engineering.
  • Major crop varieties of particular interest in this regard are agricultural crops such as maize, wheat, rice, soybean and cotton.
  • Embryo culturing has been shown to be important in making difficult interspecies crosses, while shoot-tip culturing is important in rapid clonal multiplication, development of virus-free clones and genetic resource conservation work.
  • Callus, cell, and protoplast cultures have been shown to be important for cultures in which organization is lost but can be recovered.
  • Plant genetic engineering techniques have also been established. These techniques include gene transfer by transformation or by protoplast fusion. In gene transfer, the steps involved are: (a) identification of a specific gene; (b) isolation and cloning of the gene; (c) transfer of the gene to recipient plant host cells: (d) integration, transcription and translation of the DNA in the recipient cells; and (e) multiplication and use of the transgenic plant (T. Kosuge, C.P.
  • Planta 5:551-558 (1994) described stable genetic transformation of Arabidopsis thaliana.
  • the Agrobacterium method for gene transfer was also applied to monocotyledonous plants, e.g., in plants in the Liliaceae and Amaryllidaceae families (Hooykaas-Van Slogteren et al, 1984, Nature 311:763-764), in Dioscorea bulbifera (yam) (Schafer et al, 1987, Nature 327:529-532) and in rice and maize (Ishida et al., 1996, Nat. Biotechnology 14:745-750; Hiei et al, 1997, Plant Mol Biol. 35:205-218).
  • Transformation of food crops was obtained with alternative methods, e.g., by polyethylene glycol (PEG), facilitated DNA uptake (Uchimiya et al, Mol. Gen. Genet. 204:204-207 (1986)) and electroporation (Fromm et al, Nature 319:791-793 (1986)), both of which used protoplasts as transfer targets.
  • Monocot and dicot tissues may be transformed by bombardment of tissues with DNA-coated particles (Wang et al. (1988) Plant Mol. Biol. 77:433-439; Wu, in Plant Biotechnology (1989), Kung and Arntzen, Eds., Butterworth Publishers, Stoneham, MA). Regeneration was described in rice (Abdullah et al.
  • compositions which stimulate plant growth, regeneration of plant cells and tissues, and transformation of plant cells and tissues comprise one or more mono- or multi-substituted phenylacetic acid (PA A) compounds, or ester or salt derivatives thereof, which have auxinic activity on plant cells and tissues and which have the general formula of:
  • PA A mono- or multi-substituted phenylacetic acid
  • X is one or more substitutent groups, which may be the same or different, selected from the group consisting of one or more halo- groups (particularly one or more fluoro-, chloro-, bromo-, or iodo- groups), one or more alkyl- (R-) groups, one or more alkoxy- (RO-) groups, one or more alkylamino- (RNH-) groups, one or more acyl- (RCO-) groups, one or more acylamido- (RCONH-) groups, and one or more acyloxy- (RCOO-) groups.
  • R may be CH 3 (CH 2 ) n , wherein n is an integer ranging from 0 to 10.
  • compositions comprising one or more such compounds having a substituent group at the 2, 4, 5 and/or 6 position of the PAA structure, wherein said substituents are halo-, alkyl-, alkylamino-, alkoxy-, acyl-, acylamido- or acyloxy-substituent groups having 1-10 carbon atoms.
  • compositions comprising one or more multi-substituted PAA compounds having two to five substituent groups, which may be the same or different, at positions selected from the group consisting of positions 2, 4, 5 and 6 of the IAA structure wherein said substituents are halo-, alkyl-, alkylamino-, alkoxy-, acyl-, acylamido- or acyloxy- substituent groups having 1-10 carbon atoms.
  • Preferred PAA compounds for use in compositions according to these aspects of the invention include, but are not limited to, 2- bromophenylacetic acid, 3-bromophenylacetic acid, 4-bromophenylacetic acid, and derivatives thereof and the like.
  • compositions of the invention may include, in addition to one or more of the above-described mono- or multi-substituted PAA-derived compounds, one or more additional plant growth regulators.
  • plant growth regulators include, for example, a cytokinin (such as zeatine, 6-furfurylaminopurine (kinetin) or 6-benzylaminopurine (BAP)), a gibberellin, and the like, in definite proportions for wide application to various plants.
  • the invention is exemplified with compositions comprising mono- or multi-substituted PAA compounds of the invention having between one and five substituent groups, which may be the same or different, that are halo-, alkyl-, alkylamino-, alkoxy-, acyl-, acylamido- and acyloxy-substituent groups at positions 2, 4, 5 and/or 6 of the PAA structure, and a cytokinin to affect the growth of plants.
  • the invention further relates to culture media comprising one or more of the above-described compounds or compositions of the invention.
  • Such culture media may, for example, comprise one or more of the above-described PAA compounds and optionally one or more of the above-described plant growth regulators, to stimulate plant growth, to stimulate regeneration of plant cells and tissues, and/or to stimulate transformation of plant cells and tissues.
  • the invention also relates to a method of stimulating the growth of a plant, plant cell or plant tissue comprising (a) applying to a plant, plant cell or plant tissue an effective amount of one or more of the compounds or compositions of the invention, and (b) incubating the plant, plant cell or plant tissue under conditions sufficient to stimulate the growth of the plant, plant cell or plant tissue.
  • the invention also provides a method for stimulating the regeneration of plant cells and/or tissues comprising (a) applying to a plant cell or tissue an effective amount of one or more of the compounds or compositions of the invention, and (b) incubating the plant cell or tissue under conditions sufficient to stimulate the regeneration of the plant cell or tissue.
  • the invention also relates to methods for cultivating a plant, plant cell or plant tissue in vitro, comprising (a) obtaining a plant, plant cell or plant tissue to be cultivated,
  • the invention provides a method for transformation of plant cells and/or tissues comprising (a) contacting the plant cell or tissue with a nucleic acid molecule (e.g., by transformation or protoplast fusion), (b) contacting the plant cell or tissue with an effective amount of one or more of the compounds or compositions of the invention and (c) incubating the plant cell or tissue under conditions sufficient to induce transformation of the plant cell or tissue with the nucleic acid molecule.
  • the compounds and compositions of the invention also may be used to stimulate regeneration or growth of the transformed tissue or cells, thus providing a method to obtain a transgenic plant.
  • the invention therefore also relates to transformed or transgenic plants, plant cells and plant tissues produced by the above-described methods.
  • the invention also concerns a method of attenuating or alleviating environmental stress in a plant, plant cell or tissue comprising (a) contacting a plant, plant cell or tissue which has been exposed to an environmental stress (such as drought, excess temperature, diminished temperature, chemical toxicity (e.g., antibiotic, herbicides), pollution, excess light, and diminished light) with an effective amount of one or more of the compounds or compositions of the invention, and (b) incubating said plant, plant cell or tissue under conditions sufficient to attenuate or alleviate said stress.
  • an environmental stress such as drought, excess temperature, diminished temperature, chemical toxicity (e.g., antibiotic, herbicides), pollution, excess light, and diminished light
  • Figure 1 is a diagram of the chemical structure of phenylacetic acid (PAA) and presents preferred substituents used to produce the PAA compounds used in the compounds and compositions of the invention.
  • PAA phenylacetic acid
  • Figure 2 documents the growth of tobacco (Figure 2A), tomato (Figure 2B), and potato (Figure 2C) explants, as determined by callus and root formation and plant regeneration, in response to 4-bromophenylacetic acid ("New Auxin”), in the presence of different concentrations of 6-benzylaminopurine (BAP).
  • New Auxin 4-bromophenylacetic acid
  • BAP 6-benzylaminopurine
  • PAA phenylacetic acid
  • PAA phenylacetic acid
  • PAA phenylacetic acid
  • salt and ester derivatives as the sodium, potassium, lithium, magnesium, calcium, ammonium, dimethylamine, ethanolamine, etc. salts and amides and the lower alkyl esters.
  • ammonium salts include tetralkylammonium salts such as tetramethylammonium halide and trialkylbenzylammonum halide salts, such as benzyltrimethylammonium chloride salts.
  • monosubstituted PAA as used herein refers to a PAA molecule of
  • X represents one substitutent group present at the 2, 4, 5 or 6 position of PAA, which substitutent group may be a halo- group (e.g., fluoro-, chloro-, bromo-, iodo-, etc.), an alkyl- group (R-, particularly wherein R is CH 3 (CH 2 ) n and n is an integer which may range from 0 to 10), an alkoxy- group (RO-, particularly wherein R is CH 3 (CH 2 ) n and n is an integer which may range from 0 to 10), an alkylamino- group (RNH-, particularly wherein R is CH 3 (CH 2 ) n and n is an integer which may range from 0 to 10), an acyl- group (RCO-, particularly wherein R is CH 3 (CH 2 ) n and n is an integer which may range from 0 to 10), an acylamido- group (RCONH-, particularly wherein R is CH 3 (CH 2 )
  • multi-substituted PAA refers to a PAA molecule of Figure 1 wherein X represents two or more substituent groups present at two or more of the positions corresponding to the 2, 4, 5 or 6 position in the PAA chemical structure, which substituent groups may be the same or different and which may be selected from the above-described halo-, alkyl-, alkoxy-, alkylamino-, acyl-, acylamido- and acyloxy- substitutent groups
  • auxinic analogue(s) of PAA or "PAA analogue” or “PAA auxinic analogue” or “PAA compound” as used herein may be used interchangeably, and refer to a mono- or multi-substituted PAA that comprises, for example, one or more of the above- described halo-, alkyl-, alkoxy-, alkylamino-, acyl-, acylamido- and acyloxy- substitutent groups.
  • the PAA compounds include not only the free acid forms but also amide, ester or salt forms of the mono- or multi-substituted PAA compounds.
  • a halo-group refers to a halogen including, but not limited to, iodo-, bromo-, chloro- and fluoro-groups.
  • An alkyl-group includes, but is not limited to, an R- group (linear, branched or cyclic; saturated or unsaturated), wherein R has 1-10 carbon atoms.
  • An alkoxy-group includes, but is not limited to, an RO- group (linear, branched or cyclic; saturated or unsaturated), wherein R has 1-10 carbon atoms.
  • An alkylamino-group includes, but is not limited to, an RNH- group (linear, branched or cyclic; saturated or unsaturated), wherein R has 1-10 carbon atoms.
  • An acyl-group includes, but is not limited to, an RCO- (linear, branched or cyclic; saturated or unsaturated), wherein R has 1-10 carbon atoms.
  • An acylamido-group includes, but is not limited to, an acylamido, RCONH- (linear, branched or cyclic; saturated or unsaturated), wherein R has 1-10 carbon atoms.
  • An acyloxy-group includes, but is not limited to, an acyloxy, RCOO- (linear, branched or cyclic; saturated or unsaturated), wherein R has 1-10 carbon atoms.
  • R in the above-described compounds include, but are not limited to, methyl, ethyl, ethenyl, ethynyl, propyl, isopropyl, propenyl, propynyl, butyl, isobutyl, butenyl, butynyl, pentyl, 2-pentyl, 3-pentyl, hexyl, hexenyl, heptyl, heptenyl, octyl, octenyl, nonyl, nonenyl, decyl, decenyl, and the like.
  • plant growth regulator or hormone refers to a naturally occurring or synthetic compound that acts as a hormone in regulating plant growth.
  • Plant growth regulators are exemplified by auxins, cytokinins, gibberellins, ethylene and abasic acid (ABA).
  • auxin or "cytokinin” as used herein refers to a plant growth regulator that affects the growth of plants.
  • An auxin is exemplified by a compound such as indole- 3-acetic acid (IAA), indole-3-butyric acid (IBA), 2,4-dichlorophenoxyacetic acid (2,4-D), naphthaleneacetic acid (NAA), 5,6-dichloroindole-3-acetic acid (5,6-Cl 2 -IAA) and the like.
  • a cytokinin is exemplified by a compound such as 6-benzylaminopurine (BAP), N 6 -( ⁇ 2 -isopentenyl)adenine (2iP), isopentenylpyrophosphate (ipp), 6-(4-hydroxy-3- methyl-2transbutenylamino)purine (zeatin), 6-furfurylaminopurine (kinetin) and the like.
  • BAP 6-benzylaminopurine
  • Ip isopentenylpyrophosphate
  • zeatin 6-(4-hydroxy-3- methyl-2transbutenylamino)purine
  • zeatin 6-furfurylaminopurine
  • Kinetin 6-furfurylaminopurine
  • a compound can be tested for auxin activity using a bioassay, e.g., the elongation of coleoptiles of Avena sativa (Bottger et al., Planta 140:89 (1978)) or the root growth inhibition
  • Cytokinin activity may be measured in assays designed to evaluate the promotion of growth in plants (e.g., tobacco bioassays, etc.) as is well known in the art (Skoog et al. (1967) Phytochem 6:1169-1192; Morris, Ann. Rev. Plant Physiol 37:509-538 (1986); Horgan (1984) Advanced Plant Physiol (Wilkins, M.B., ea.) Pitman Publishing, London, pp. 53-75; Letham and Palni, Ann. Rev.
  • cytokinin/auxin concentration ratio causes the enhancement in plant growth to occur preferentially in certain tissues. For example, a high cytokinin/auxin ratio promotes growth of shoots, whereas a low cytokinin/auxin ratio promotes the growth of roots (Depicker et al. (1983) Genetic Engineering of Plants (T. Kosunge, C. P. Meredith and A. Hollaender, eds.) Plenum Press, New York, p. 154).
  • medium refers to a solid or liquid composition comprising nutrients sufficient to support the in vitro cultivation, growth, regeneration and/or transformation of plants, plant cells, plant tissues, protoplasts and the like.
  • a plant culture medium is composed of a number of ingredients and these ingredients vary from one culture medium to another.
  • a "IX formulation” is meant to refer to any aqueous solution that contains some or all ingredients found in a plant culture medium at working concentrations.
  • the "IX formulation” can refer to, for example, the plant culture medium or to any subgroup of ingredients for that medium.
  • the concentration of an ingredient in a IX solution is about the same as the concentration of that ingredient found in a plant culture formulation used for maintaining or cultivating plant cells or tissues in vitro.
  • a plant culture medium used for the in vitro cultivation of plants, plant cells, plant tissues and the like, is a IX formulation by definition.
  • each ingredient in a IX formulation has a concentration about equal to the concentration of those ingredients in a plant culture medium.
  • Gamborg's B-5 plant culture medium contains, among other ingredients, 0.134 g/L ammonium sulfate, 2.5 g/L potassium nitrate, and 20 g/L sucrose.
  • a " IX formulation" of these medium components contains about the same concentrations of these ingredients in solution.
  • each ingredient in solution has the same or about the same concentration as that found in the plant culture medium being described.
  • concentrations of ingredients in a IX formulation of plant culture medium are well known to those of ordinary skill in the art.
  • a 10X formulation is meant to refer to a solution wherein each ingredient in that solution is about 10 times more concentrated than the same ingredient in the plant culture medium.
  • a 10X formulation of Gamborg's B-5 plant culture medium may contain, among other ingredients, 1.34 g/L ammonium sulfate, 25 g/L potassium nitrate, and 200 g/L sucrose (compare IX formulation, above).
  • a “10X formulation” may contain a number of additional ingredients at a concentration about 10 times that found in the IX culture medium.
  • "20X formulation,” “25X formulation,” “50X formulation” and “100X formulation” designate solutions that contain ingredients at about 20-, 25-, 50- or 100- fold concentrations, respectively, as compared to a IX culture medium.
  • the osmolality and pH of the media formulation and concentrated solution may vary. See U.S. Patent No. 5,474,931, which is directed to culture media concentrate technology, the disclosure of which is incorporated by reference herein in its entirety.
  • carrier refers to a chemically- or biologically- or physiologically-acceptable molecule that is hydrophobic or hydrophilic or amphoteric and that is useful in facilitating the effectiveness of an active ingredient (i.e., a PAA analogue of the invention) in a plant.
  • a plant refers to a whole plant or a part of a plant comprising, for example, a locus of a plant, a cell of a plant, a tissue of a plant, an embryo of a plant, an explant, or seeds of a plant. This term further contemplates a plant in the form of a suspension culture or a tissue culture including, but not limited to, a culture of calli, protoplasts, embryos, organs, organelles, etc.
  • transformed plant or transformed plant tissues as used herein refers to introduction of a nucleic acid molecule, e.g., native or foreign DNA, into a plant or plant tissue by transformation or protoplast fusion.
  • transgenic plant or “transgenic plant tissue” as used herein refers to a plant or plant tissue stably transformed with a foreign gene.
  • transient expression refers to a plant or plant tissue transformed with a DNA, where that DNA is expressed only for a short period of time immediately after transformation.
  • genetic engineering refers to the introduction of foreign, often chimeric, genes into one or more plant cells which can be regenerated into whole, sexually competent, viable plants which can be self-pollinated or cross-pollinated with other plants of the same species so that the foreign gene, carried in the germ line, can be inserted into or bred into agriculturally useful plant varieties.
  • regeneration refers to the production of at least one newly developed or regenerated plant tissue, e.g., root, shoot, callus, etc., from a cultured plant tissue or unit, e.g., leaf disc, seed, etc.
  • percent refers to the number of tissue cultured plant units producing at least one newly developed or regenerated tissue as a percentage of the total number of tissue cultured plant units, e.g., (number of leaf discs with shoots X 100) total number of leaf discs
  • affecting plant growth or “growth affecting” or “affector” or “affect” as used herein refer to any one of a number of plant responses which improve or change, relative to what is observed in the absence of the growth regulator, some characteristic of overall plant growth, for example, stimulation of seed germination, inducing rooting, suppressing shooting, promoting cell proliferation, stimulating callus growth, etc. It is further understood that within the context of the present invention, these terms may also encompass toxic effects on plant tissues.
  • the term "effective amount” as used herein refers to the amount or concentration of a compound such as a plant growth regulator or hormone, administered to a plant such that the compound stimulates or invokes one or more of a variety of plant growth responses.
  • a plant growth response includes, among others, the induction of stem elongation, the promotion of root formation, the stimulation of callus formation, enhancement of leaf growth, stimulation of seed germination, increase in the dry weight content of a number of plants and plant parts, and the like.
  • the present invention relates generally to compositions which stimulate plant growth, regeneration of plant cells and tissues, and transformation of plant cells and tissues.
  • the compositions of the invention comprise one or more mono- or multi- substituted phenylacetic acid (PAA) compounds, or ester or salt derivatives thereof, which have auxinic activity on plant cells and tissues.
  • PAA mono- or multi- substituted phenylacetic acid
  • the invention contemplates the use of such PAA compounds to affect growth, regeneration and transformation in both monocotyledonous and dicotyledonous plants.
  • various PAA compounds were screened for auxinic activity by incubating different plant tissues, e.g., tobacco and tomato leaf discs, and potato stems in (a) MS complete medium (obtained from Life).
  • the potato tissue is transferred from a medium containing a high amount of auxin to another medium containing auxin and cytokinin.
  • the regeneration of shoots from potato tissue was obtained without tissue transfer from a high auxin medium to a medium containing auxin and cytokinin.
  • the regeneration of shoots in potato tissue, according to the invention showed significant improvement in the number of shoots regenerated.
  • the compositions of the present invention not only exhibit auxinic activity but also improve the yield of plant tissue regenerated, as exemplified in plant tissues traditionally described as being difficult to regenerate, e.g., cassava, woody plants, maize, soybean, wheat, etc.
  • the practice of the present invention contemplates a wide variety of plant growth responses, including stimulation of seed germination and breaking of dormancy; increasing yields; hastening ripening and color production in fruit; increasing flowering and fruiting; stimulating shoot formation; inducing callus development; inducing rooting and causing cell proliferation; increasing the hardiness of various plant species; and increasing the dry weight content of a number of plants and plant parts.
  • any other modification of a plant, seed, fruit or vegetable so long as the net result is to increase the growth or maximize any beneficial or desired property of the agricultural and horticultural crop or seed, is intended to be included within the scope of advantageous responses achieved by the practice of the present invention.
  • Suitable applications of the growth enhancing compositions of the present invention to cultures of plant tissues induce the regeneration of shoots, roots or calli. This effect occurs in both monocotyledonous and dicotyledonous plant species and applies to a wide variety of plants.
  • compositions of the invention comprise one or more mono- or multi- substituted phenylacetic acid (PAA) compounds, or ester or salt derivatives thereof, which have auxinic activity on plant cells and tissues.
  • PAA phenylacetic acid
  • Compounds according to this aspect preferably have the general formula:
  • X is one or more substitutent groups, which may be the same or different, and which is selected from the group consisting of one or more halo- groups (particularly one or more fluoro-, chloro-, bromo- or iodo- groups) one or more alkyl- (R-) groups, one or more alkoxy- (RO-) groups, one or more alkylamino- (RNH-) groups, one or more acyl- (RCO-) groups, one or more acylamido- (RCONH-) groups and one or more acyloxy- (RCOO-) groups.
  • R may be CH 3 (CH 2 ) n , wherein n is an integer ranging from 0 to 10.
  • compositions comprising one or more mono- substituted PAA compounds having a substituent group at the 2, 4, 5 and/or 6 position of the PAA structure ( Figure 1), wherein the substituent group is a halo-, alkyl-, alkylamino-, alkoxy-, acyl-, acylamido- or acyloxy-substituent group having 1-10 carbon atoms.
  • compositions comprising one or more multi- substituted PAA compounds having two to five substituent groups, which may be the same or different, at positions selected from the group consisting of positions 2, 4, 5 and 6 of the PAA structure ( Figure 1) wherein the substituents are halo-, alkyl-, alkylamino-, alkoxy-, acyl-, acylamido- or acyloxy-substituent groups having 1-10 carbon atoms.
  • Preferred PAA compounds for use in compositions according to these aspects of the invention include, but are not limited to, 2-bromophenylacetic acid, 3-bromophenylacetic acid, 4-bromophenylacetic acid, 4-chlorophenylacetic acid, and derivatives thereof.
  • PAA compounds are preferably included in the compositions of the invention at concentrations that promote optimal growth, cultivation, regeneration or transformation of plant cells, tissues, etc.
  • Preferred concentration ranges of PAA compounds for use in the present compositions include, without limitation, about 0.01 mg/ml to about 100 mg/ml, about 0.05 mg/ml to about 100 mg/ml, about 0.1 mg/ml to about 50 mg/ml, about 0.5 mg/ml to about 50 mg/ml, about 0.75 mg/ml to about 25 mg/ml, about 1 mg/ml to about 25 mg/ml, about 2 mg/ml to about 20 mg/ml, about 2.5 mg/ml to about 20 mg/ml, about 2.5 mg/ml to about 15 mg/ml, about 2.5 mg/ml to about 10 mg/ml, about 2.5 mg/ml to about 9 mg/ml, about 2.5 mg/ml to about 8 mg/ml, about 2.5 mg/ml to about 7.5 mg/ml, about 2.5 mg/ml to about
  • PAA compounds are preferably included in the compositions of the present invention at concentrations that cause toxic effects on plant tissues.
  • Further preferred concentration ranges of PAA compounds for use in the present compositions include, without limitation, about 0.5 mg/1 to about 1000 mg/1, about 0.5 mg/1 to about 850 mg/1, about 0.5 mg/1 to about 750 mg/1, about 0.5 mg/1 to about 650 mg/1, about 0.5 mg/ml to about 500 mg/ml, about 0.5 mg/1 to about 350 mg/1, about 0.5 mg/ml to about 250 mg/1, about 0.5 mg/1 to about 150 mg/1, about 0.5 mg/1 to about 100 mg/1, about 0.5 mg/1 to about 50 mg/1, and about 0.5 mg/1 to about 20 mg/1.
  • compositions of the invention may include, in addition to one or more of the above-described mono- or multi-substituted PAA-derived compounds, one or more additional plant growth regulators.
  • additional plant growth regulators for example, it is contemplated that other cytokinins or other plant growth regulators known in the art can be utilized with one or more PAA compounds to make additional growth-affecting compositions of the invention.
  • Plant growth regulators that may be advantageously used in the compositions of the invention are known in the art and include, but are not limited to, BAP, 2iP, ipp, zeatin, kinetin, gibberellin, and the like, as described in Skoog et al, Phytochemistry 6: 1169-1192 (1967) and Theologis (1989) Plant Biotechnology (Kung and Arntzen, eds.) Butterworth Publishers, Stoneham, MA, in definite proportions for wide application to various plants.
  • compositions comprising one or more mono- or multi-substituted PAA compounds having between one and five substituent groups, which may be the same or different and which may be halo-, alkyl-, alkylamino-, alkoxy-, acyl-, acylamido- and acyloxy-substituent groups at positions 2, 4, 5 and/or 6 of the PAA structure, and one or more cytokinins to affect the growth of plants.
  • the one or more cytokinins or other growth regulators may be used in the compositions of the invention at concentration ranges that promote optimal growth, cultivation, regeneration, or transformation of plant cells, tissues, etc.
  • concentration ranges of cytokinins or other growth regulators for use in the present compositions include, without limitation, about 0.01 mg/ml to about 100 mg/ml, about 0.05 mg/ml to about 100 mg/ml, about 0.1 mg/ml to about 50 mg/ml, about 0.5 mg/ml to about 50 mg/ml, about 0.75 mg/ml to about 25 mg/ml, about 1 mg/ml to about 25 mg/ml, about 2 mg/ml to about 20 mg/ml, about 2.5 mg/ml to about 20 mg/ml, about 2.5 mg/ml to about 15 mg/ml, about 2.5 mg/ml to about 10 mg/ml, about 2.5 mg/ml to about 9 mg/ml, about 2.5 mg/ml to about 8 mg/ml, about 2.5
  • the concentration of a given cytokinin or other growth regulator can be increased or decreased beyond the ranges described above, and the effect of the increased or decreased concentration on plant growth, cultivation, regeneration or transformation can be determined using routine experimentation.
  • the precise amount of growth affecting compositions employed in the practice of the present invention will depend upon the type of response desired, the formulation used, and the type of plant treated.
  • the invention contemplates the use of a ratio of cytokinin or other growth regulator concentration to PAA analogue concentration of between approximately 50.0 and 0.001, preferably between approximately 5.0 and 0.05, and more preferably between approximately 2.0 and 0.25.
  • the invention further relates to plant culture media comprising one or more of the above-described PAA compounds or compositions of the invention.
  • Such culture media may, for example, comprise one or more of the above-described PAA compounds and optionally one or more of the above-described plant growth regulators, to stimulate plant growth, to stimulate regeneration of plant cells and tissues and to stimulate transformation of plant cells and tissues.
  • the cell culture media according to this aspect of the invention are aqueous-based or solid or semi-solid, comprising a number of ingredients in a solution of deionized, distilled water to form "basal media.”
  • Ingredients which may be in the basal media of the present invention include amino acids, vitamins, inorganic salts, D-glucose, sucrose, MES, glycine and solidified reagents such as agar, agrose, gelrite, charcoal and coconut. Each of these ingredients may be obtained commercially, for example from Sigma (Saint Louis, Missouri).
  • Amino acid ingredients which may be included in the media of the present invention include L-alanine, L-arginine, L-asparagine, L-aspartic acid, L-cysteine, L- glutamic acid, L-glutamine, glycine, L-histidine, L-isoleucine, L-leucine, L-lysine, L- methionine, L-phenylalanine, L-proline, L-serine, L-threonine, L-tryptophan, L-tyrosine and L-valine. These amino acids may be obtained commercially, for example from Sigma (Saint Louis, Missouri).
  • Vitamin ingredients which may be included in the media of the present invention include biotin, choline chloride, D-Ca ⁇ -pantothenate, folic acid, z ' -inositol, niacinamide, pyridoxine, riboflavin, thiamine and vitamin B 12 . These vitamins may be obtained commercially, for example from Sigma (Saint Louis, Missouri).
  • Inorganic salt ingredients which may be used in the media of the present invention include a calcium salt (e.g., CaCl 2 ), CuSO , FeSO 4 , KC1, a magnesium salt (e.g., MgCl 2 ), a manganese salt (e.g., MnCl 2 ), sodium acetate, NaCl, NaHCO 3 , Na 2 HPO , Na 2 SO 4 , and ions of the trace elements selenium, silicon, molybdenum, vanadium, nickel, tin and zinc.
  • a calcium salt e.g., CaCl 2
  • CuSO , FeSO 4 , KC1
  • MgCl 2 magnesium salt
  • MnCl 2 manganese salt
  • sodium acetate NaCl, NaHCO 3 , Na 2 HPO , Na 2 SO 4
  • ions of the trace elements selenium, silicon, molybdenum, vanadium, nickel, tin and zinc.
  • trace elements may be provided in a variety of forms, preferably in the form of salts such as Na 2 SeO 3 , Na 2 SiO 3 , (NH 4 )6Mo 7 O 24 , NH 4 VO 3 , NiSO 4 , SnCl and ZnSO.
  • salts such as Na 2 SeO 3 , Na 2 SiO 3 , (NH 4 )6Mo 7 O 24 , NH 4 VO 3 , NiSO 4 , SnCl and ZnSO.
  • These inorganic salts and trace elements may be obtained commercially, for example from Sigma (Saint Louis, Missouri).
  • plant cell culture media examples include, but are not limited to, Anderson's Plant Culture Media, CLC Basal Media, Gamborg's Media, Guillard's Marine Plant Culture Media, Provasoli's Marine Media, Kao and Michayluk's Media, Murashige and Skoog Media, McCown's Woody Plant Media, Knudson Orchid Media, Lindemann Orchid Media, and Vacin and Went Media.
  • Formulations for these media which are commercially available, as well as for many other commonly used plant cell culture media, are well-known in the art and may be found for example in the GIBCO BRL Products and Reference Guide (Life Technologies, Inc., Rockville, Maryland), and in the Sigma Plant Cell Culture Catalogue (Sigma; St. Louis, Missouri).
  • any of the above media of the invention may also include one or more additional components, such as indicating or selection agents (e.g., dyes, antibiotics, amino acids, enzymes, substrates and the like), filters (e.g., charcoal), salts, polysaccharides, ions, detergents, stabilizers, and the like.
  • the above-described culture media may comprise one or more buffer salts, at concentrations sufficient to provide optimal buffering capacity for the culture medium.
  • a buffer salt may be added in powdered form to the powdered medium prior to, during or following addition of the one or more PAA compounds and optionally the one or more cytokinins or other growth regulators to the medium.
  • the medium ingredients can be dissolved in a liquid carrier or maintained in dry form. If dissolved in a liquid carrier at the preferred concentrations shown in Table 1 (i.e., a "IX formulation"), the pH of the medium should be adjusted to about 4-8, preferably about 4.5-7, 5-6 or 5.5-6. Of course, optimal pH for a given culture medium to be used on a particular cell type may also be determined empirically by one of ordinary skill in the art using known methods.
  • the type of liquid carrier and the method used to dissolve the ingredients into solution vary and can be determined by one of ordinary skill in the art with no more than routine experimentation.
  • the medium ingredients can be added in any order.
  • each of the components of the culture medium may react with one or more other components in the solution.
  • the present invention encompasses the culture media supplemented as described above with one or more PAA compounds and optionally also with one or more cytokinins or other plant growth regulators, as well as any reaction mixture which forms after these ingredients are combined.
  • the solutions comprising ingredients are more concentrated than the concentration of the same ingredients in a IX media formulation.
  • the ingredients can be 10-fold more concentrated (10X formulation), 20-fold more concentrated (20X formulation), 25-fold more concentrated (25X formulation), 50-fold more concentrated (50X concentration), or 100-fold more concentrated (100X formulation). More highly concentrated formulations can be made, provided that the ingredients remain soluble and stable. See U.S. Patent No. 5,474,931, which is directed to methods of solubilizing culture media components at high concentrations.
  • the media ingredients are prepared as separate concentrated solutions, an appropriate (sufficient) amount of each concentrate is combined with a diluent to produce a IX medium formulation.
  • the diluent used is water but other solutions including aqueous buffers, aqueous saline solution, or other aqueous solutions may be used according to the invention.
  • the culture media of the invention may be prepared in dry powder form and then agglomerated with one or more solvents, preferably an aqueous solvent such as water or a saline solution, to produce an agglomerated dry powder plant culture medium that will more readily dissolve upon reconstitution.
  • solvents preferably an aqueous solvent such as water or a saline solution
  • the culture media of the present invention is typically sterilized to prevent unwanted contamination. Sterilization may be accomplished, for example, by filtration through a low protein-binding membrane filter of about 0.1-1.0 ⁇ m pore size (available commercially, for example, from Millipore, Bedford, Massachusetts) after admixing the concentrated ingredients to produce a sterile culture medium. Alternatively, concentrated subgroups of ingredients may be filter-sterilized and stored as sterile solutions. These sterile concentrates can then be mixed under aseptic conditions with a sterile diluent to produce a concentrated IX sterile medium formulation.
  • Dry powder culture media of the invention may be sterilized by irradiation, for example with ⁇ irradiation or ultraviolet irradiation, as described in commonly owned, co-pending U.S. Application No. 09/023,790, filed February 13, 1998.
  • the culture media of the invention are exemplified herein as suitable for cultivation of rice, maize, wheat, tobacco, potato and soybean
  • the present culture media may be used to support the growth, cultivation, regeneration and transformation in vitro of cells, tissues, embryos, protoplasts, and the like from any plant species.
  • Suitable methods for isolation and in vitro cultivation of plants, plant cells, plant tissues, and the like are well-known to those of ordinary skill in the art (see, e.g., U.S. Patent No. 5,674,731 , the disclosure of which is incorporated by reference herein in its entirety).
  • the present compounds, compositions and culture media of the invention may be used in a variety of methods used for stimulating growth, regeneration, transformation, or cultivation of plant cells, tissues, protoplasts, embryos and the like.
  • the present invention relates to methods of stimulating the growth or regeneration of a plant, plant cell or plant tissue comprising (a) applying to a plant, plant cell or plant tissue an effective amount of one or more of the compounds or compositions of the invention, and (b) incubating the plant, plant cell or plant tissue under conditions sufficient to stimulate the growth or regeneration of the plant, plant cell or plant tissue, for example in one or more of the culture media of the invention.
  • the invention also provides methods for stimulating the regeneration of plant cells and/or tissues comprising (a) applying to a plant cell or tissue an effective amount of one or more of the compounds or compositions of the invention, and (b) incubating the plant cell or tissue under conditions sufficient to stimulate the regeneration of the plant cell or tissue.
  • the invention also concerns methods of attenuating or alleviating environmental stress in a plant, plant cell or tissue comprising (a) contacting a plant, plant cell or tissue which has been exposed to an environmental stress (such as drought, excess temperature, diminished temperature, chemical toxicity (e.g., antibiotic, herbicides), pollution, excess light and diminished light) with an effective amount of one or more of the compounds or compositions of the invention, and (b) incubating said plant, plant cell or tissue under conditions sufficient to attenuate or alleviate said stress.
  • an environmental stress such as drought, excess temperature, diminished temperature, chemical toxicity (e.g., antibiotic, herbicides), pollution, excess light and diminished light
  • the invention also relates to methods for cultivating a plant, plant cell or plant tissue in vitro, comprising (a) obtaining a plant, plant cell or plant tissue to be cultivated, (b) contacting the plant, plant cell or plant tissue with one or more of the compounds or compositions of the invention, and (c) incubating the plant, plant cell or plant tissue under conditions suitable to support cultivation of the plant, plant cell or plant tissue.
  • the invention provides a method for transformation of plant cells and/or tissues comprising (a) contacting the plant cell or tissue with a nucleic acid molecule (e.g., by transformation or protoplast fusion), (b) contacting the plant cell or tissue with an effective amount of one or more of the compounds or compositions of the invention, and (c) incubating the plant cell or tissue under conditions sufficient to induce transformation of the plant cell or tissue with the nucleic acid molecule.
  • the compounds and compositions of the invention may also be used to stimulate regeneration or growth of the transformed tissue or cells, thus providing a method to obtain a transgenic plant.
  • the invention therefore also relates to transformed or transgenic plants, plant cells and plant tissues produced by the above-described methods.
  • Suitable applications of the growth-enhancing compounds and compositions of the present invention include contacting cultures of plant tissues with one or more of the compounds or compositions of the invention to induce the regeneration of shoots, roots or calli. This effect occurs in both monocotyledonous and dicotyledonous plant species and applies to a wide variety of plants.
  • the compounds and compositions of the present invention may further be utilized for plant regeneration from transgenic plants.
  • Genetic engineering of plants generally involves two complementary processes.
  • the first process involves the genetic transformation of one or more plant cells of a specifically characterized type.
  • transformation it is meant that a foreign gene, typically a chimeric gene construct, is introduced into the genome of the individual plant cells, typically through the aid of a vector which has the ability to transfer the gene of interest into the genome of the plant cells in culture.
  • the second process then involves the regeneration of the transformed plant cells into whole sexually competent plants. Neither the transformation nor regeneration process need be 100% successful but must have a reasonable degree of reliability and reproducibility so that a reasonable percentage of the cells can be transformed and regenerated into whole plants.
  • the two processes, transformation and regeneration, must be complementary.
  • the complementarity of the two processes must be such that the tissues which are successfully genetically transformed by the transformation process must be of a type and character, and must be in sufficient health, competency and vitality, so that they can be successfully regenerated into whole plants.
  • the invention envisions the genetic transformation of tissues in culture derived from leaf discs or hypocotyl explants.
  • the transformed tissues can be induced to form plant tissue structures, which can be regenerated into whole plants.
  • the transformation technique of the present invention is one which makes use of the Ti plasmid of A. tumefaciens.
  • an A. tumefaciens culture as a transformation vehicle, it is most advantageous to use a non-oncogenic strain of the Agrobacterium as the vector carrier so that normal non-oncogenic differentiation of the transformed tissue is possible.
  • the chimeric construction including a foreign gene of interest must contain a promoter which is effective in plant cells to cause transcription of the gene of interest and a polyadenylation sequence or transcription control sequence also recognized in plant cells.
  • Promoters known to be effective in plant cells include the nopaline synthase promoter, isolated from the T-DNA of Agrobacterium, and the cauliflower mosaic virus 35S promoter. Other suitable promoters are known in the art. It is also preferred that the vector which harbors the foreign gene of interest also contain therein one or more selectable marker genes so that the transformed cells can be selected from non-transformed cells in culture. In many applications, preferred marker genes include antibiotic resistance genes so that the appropriate antibiotic can be used to segregate and select for transformed cells from among cells which are not transformed.
  • the details of the construction of the vectors containing such foreign genes of interest are known to those skilled in the art of plant genetic engineering and do not differ in kind from those practices which have previously been demonstrated to be effective in tobacco, petunia and other model plant species.
  • the foreign gene should obviously be selected as a marker gene (Jefferson et al, EMBO J. ⁇ 5:3901-3907 (1987)) or to accomplish some desirable effect in plant cells. This effect may be growth promotion, disease resistance, a change in plant morphology or plant product quality, or any other change which can be accomplished by genetic manipulation.
  • the chimeric gene construction can code for the expression of one or more exogenous proteins, or can cause the transcription of negative strand RNAs to control or inhibit either a disease process or an undesirable endogenous plant function.
  • tissues are seeds, the seeds are then allowed to germinate on an appropriate germinating medium containing a fungicide.
  • the hypocotyl portion of the immature plant is removed and sectioned into small segments averaging approximately 0.5 centimeters apiece. The hypocotyl explants are allowed to stabilize and remain viable in a liquid or agar plant tissue culture medium.
  • the tissues Once the tissues have stabilized, they can promptly be inoculated with a suspension culture of transformation competent non-oncogenic Agrobacterium.
  • the inoculation process is allowed to proceed for a short period, e.g., two days, at room temperature, i.e., 24°C.
  • the remaining treated tissues can be transferred to a selective agar medium, which contains one or more antibiotics toxic to Agrobacterium but not to plant tissues, at a concentration sufficient to kill any Agrobacterium remaining in the culture.
  • Suitable antibiotics for use in such a medium include carbenicillin, cefotaxime, etc., as the bactericide for Agrobacterium and kanamycin as the selective antibiotic for transformed plant tissues.
  • the tissues may then be cultivated on a tissue culture medium, preferably a culture medium of the invention, which, in addition to its normal components, contains one or more selection agents.
  • the selection agent exemplified herein by kanamycin, is toxic to non-transformed cells but not to transformed cells which have incorporated genetic resistance to the selection agent and are expressing that resistance.
  • the surviving transformed tissues are transferred to a secondary medium, preferably a culture medium of the invention with the selection agent, to induce tissue regeneration.
  • the surviving transformed tissue will thus continue to be regenerated into a whole plant through the regeneration technique of the present invention or through any other alternative plant regeneration protocols.
  • PAA compounds and compositions of the invention are also useful in making a plant less susceptible to the toxicities of antibiotics.
  • Such PAA compounds and compositions are also useful in enabling plants to overcome stress, e.g., environmental stress, physical stress, chemical stress, pollution, contamination, drought, light, and the like.
  • the present compounds and compositions may be applied at any developmental stage of the plant species to obtain plant hormone or maintenance effects throughout maturity and to expedite re-growth in damaged tissues during early developmental stages, depending upon the concentration used, the formulation employed and the type of plant species treated.
  • the compounds and compositions of the present invention are preferably used in conjunction with specific auxiliary nutrients or other plant growth regulators in precise proportions to achieve a particular synergistic, growth enhancing response in various type of plants.
  • the present compounds and compositions may additionally be used in association with fungicides to increase the disease resistance of various plants, making the plant tissue resistant to invasion by pathogens by influencing the enzyme and plant processes which regulate natural disease immunity. While the present compounds and compositions possess essentially no phytotoxic activity of their own, they may sometimes be used in conjunction with herbicides to stimulate the growth of unwanted plants in order to make such plants more susceptible to a herbicide. However, it is preferred to regard the results achieved in the practice of the present invention as growth enhancing responses in agricultural and horticultural crops, as well as perennial and annual household plants species.
  • Plant Material Seeds of Rice (Oryza sativa L.), Sweetcorn (Zea mays) and Wheat (Triticurn aestivam L.) were sterilized by first placing them in sterile water while gently stirring for 30 minutes. The seeds were then immersed in 95% alcohol for 1 min. The alcohol solution was remove and the seeds were placed into a Side-arm-flask. A solution of 15% commercial bleach plus 0.1% Tween ® 20 was prepared and added to the flask. A vacuum was applied to the seeds for 20 minutes while shaking. The vacuum was removed but shaking continued for an additional 25 min. The seeds were rinsed three times with sterile water in a clean hood, and planted in semi-solid MS medium.
  • Tobacco Nicotiana tobaccum cv. Xanti
  • Tomato Lycopersicon esculentum L. Mill.
  • young leaves from one-month-old plants were removed and punched by hole puncher to prepare uniform leaf discs.
  • the leaf discs were placed into MS complete media in petri dishes.
  • Potato Solanum tuberosus cv. Atlantic
  • Cassava Manihot esculenta
  • Soybean For cultivation of Soybean (Glycine max L.), seeds were sterilized by placing them into 95% ethanol for 3 minutes. The ethanol was then removed, 10% bleach was added, and the seeds were stirred for 15 minutes. The seeds were then transferred directly from the bleach solution into sterile MS medium (7 seeds per plate). The plates were incubated in the dark at 28°C for 4 days. The plates were then inspected for fungi and bacteria, and clean seeds were transferred to Magenta Boxes and incubated for an additional 11 days. The resulting 15 day old Soybean stems were cut into segments approximately 1 cm long and placed into MS medium in petri dishes.
  • auxin-like chemicals were evaluated for auxin activity by incubating the tobacco leaf discs, tomato leaf discs and potato stems in culture medium containing MS salts and different concentrations of either auxin-like chemicals only, or a combination of auxin-like chemicals and cytokinin. Callus or root formation was observed in the medium containing the auxin-like chemicals only, while the regeneration of shoots was also found in addition to root and/or callus formation in the medium containing auxin-like chemicals and cytokinin. In general, more callus formation was observed in the combination of cytokinin with high concentration of auxin-like chemicals (Figure 2).
  • the potato stems were incubated onto the medium containing 4- bromophenylacetic acid with different cytokinine and kanamycin for the selection of antibiotics resistant plants.
  • the transformation efficiency was increased about 40 fold in agar based culture, and 95 fold in membrane based liquid culture for the Atlantic variety.
  • the transformation efficiency were improved from 0 to 10-25 fold in agar based culture, and 0 to 57-920 fold in the membrane based liquid culture (Table 5).

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Environmental Sciences (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Plant Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Dentistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Cultivation Of Plants (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EP99956730A 1998-10-28 1999-10-28 Zusammensetzungen, die das wachstum von pflanzenzellen regulierende verbindungen enthalten, und verfahren zu ihrer verwendung Withdrawn EP1124417A2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10599998P 1998-10-28 1998-10-28
US105999P 1998-10-28
PCT/US1999/025263 WO2000024249A2 (en) 1998-10-28 1999-10-28 Compositions comprising plant cell growth regulating compounds and methods of use thereof

Publications (1)

Publication Number Publication Date
EP1124417A2 true EP1124417A2 (de) 2001-08-22

Family

ID=22308940

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99956730A Withdrawn EP1124417A2 (de) 1998-10-28 1999-10-28 Zusammensetzungen, die das wachstum von pflanzenzellen regulierende verbindungen enthalten, und verfahren zu ihrer verwendung

Country Status (5)

Country Link
EP (1) EP1124417A2 (de)
JP (1) JP2002528394A (de)
AU (1) AU1327000A (de)
CA (1) CA2348411A1 (de)
WO (1) WO2000024249A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014090988A1 (en) * 2012-12-14 2014-06-19 Vib Vzw Agrochemical compositions for inducing abiotic stress tolerance
AU2020277499B2 (en) * 2019-05-23 2026-02-12 Galy Co. Compositions and methods for plant cell culture

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01281078A (ja) * 1988-05-09 1989-11-13 Tsumura & Co 新規カルス誘導細胞および該カルス誘導細胞の製造方法
DE4447287C1 (de) * 1994-12-30 1996-11-07 Cevc Gregor Präparat zum Wirkstofftransport durch Barrieren
BR9807886A (pt) * 1997-03-26 2000-02-22 Univ Cambridge Tech Processo para se obter uma planta com caracterìsticas de crescimento alteradas ou arquitetura alterada, gene quimérico, célula de planta, planta, semente da mesma, fragmento isolado de dna, e, usos de uma proteìna que controla a divisão celular, e de um dna que codifica a mesma

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO0024249A3 *

Also Published As

Publication number Publication date
WO2000024249A2 (en) 2000-05-04
CA2348411A1 (en) 2000-05-04
JP2002528394A (ja) 2002-09-03
AU1327000A (en) 2000-05-15
WO2000024249A3 (en) 2001-03-22

Similar Documents

Publication Publication Date Title
EP0827532B1 (de) Regeneration sowohl von pflanzengewebe als auch transgenen pflanzengewebe mittels einem neuartigen pflanzenhormon 5-bromindol-3-essigsäure
Vasil et al. Plant cell and tissue culture
Deo et al. Factors affecting somatic embryogenesis and transformation in modern plant breeding
US8404930B2 (en) Methods for improving monocot transformation
FI110009B (fi) Camelina sativan transformaatiojärjestelmä
US6361999B1 (en) Auxinic analogues of indole-3- acetic acid
US20070006351A1 (en) Method for regenerating and transforming St. Augustinegrass from embryogenic callus
Ghosh et al. In vitro shoot grafting on rootstock: an effective tool for Agrobacterium-mediated transformation of pigeonpea (Cajanus cajan (L.) Millsp.)
CN102250943A (zh) 一种农杆菌介导的大豆离体组织培养方法
US20110162111A1 (en) Method for transforming somatic embryos
EP1124417A2 (de) Zusammensetzungen, die das wachstum von pflanzenzellen regulierende verbindungen enthalten, und verfahren zu ihrer verwendung
US20060030487A1 (en) Materials and methods for the regeneration of plants from cultured plant tissue
WO2001067861A1 (en) Materials and methods for the regeneration of plants from cultured plant tissue
EP0866850A1 (de) Auxin analoge
WO1997020034A9 (en) Auxinic analogues of indole-3-acetic acid
Yadav et al. Tissue culture strategies in sugarcane (Saccharum officinarum L.)
Ahmed AVOCADOS (Persea americana Mill.)
ALI et al. regeneration and transformation system in egyptian sweet potato (Ipomoea batatas Lam.) CULTIVARS
Guruprasad et al. A review on maize (Zea mays L.) transformation for expression of insecticidal proteins.
US20090293157A1 (en) Production of progenitor cereal cells
WO2016094029A1 (en) Methods of embryogenic tissue preparation for sugar cane transformation
PRIYA TISSUE CULTURE OF IR 64 AND SWARNA
Chutipaijit et al. Factors of Callus and Combination of Plant Growth Regulators Effect On the Plant Regeneration from Scutellum of Indica Rice (Oryza sativa L. cv. KDML 105)
Dhillon STUDIES ON SOMATIC EMBRYOGENESIS AND GENETIC TRANSFORMATION IN MAIZE
CHILLI COLLEGE OF HORTICULTURE

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010515

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL PAYMENT 20010515;LT PAYMENT 20010515;LV PAYMENT 20010515;MK PAYMENT 20010515;RO PAYMENT 20010515;SI PAYMENT 20010515

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20070503